Maria Moris1, Mellena D Bridges2, Robert A Pooley2, Massimo Raimondo3, Timothy A Woodward3, John A Stauffer4, Horacio J Asbun4, Michael B Wallace5. 1. Department of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida; Programa de Doctorat en Medicina de la Universitat Autònoma de Barcelona, Barcelona, Spain. 2. Department of Radiology, Mayo Clinic, Jacksonville, Florida. 3. Department of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida. 4. Department of General Surgery, Mayo Clinic, Jacksonville, Florida. 5. Department of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida. Electronic address: wallace.michael@mayo.edu.
Abstract
BACKGROUND & AIMS: Increasingly, pancreatic cysts are discovered incidentally in patients undergoing cross-sectional imaging for nonpancreatic reasons. It is unclear whether this increase is caused by improved detection by progressively more sophisticated cross-sectional imaging techniques or by a true increase in prevalence. We aimed to determine the prevalence of incidental pancreatic cysts in patients undergoing magnetic resonance imaging (MRI) for nonpancreatic indications on successive, increasingly sophisticated MRI systems. Also, we compared prevalence based on the demographic characteristics of the patients. METHODS: We collected data from MRIs performed at the Mayo Clinic in Florida during the sample months of January and February, from 2005 to 2014. Each patient's clinical chart was reviewed in chronological order to include the first 50 MRIs of each year (500 total). Patients were excluded if they had pancreatic disease including cysts, pancreatic surgery, pancreatic symptoms, pancreatic indication for the imaging study, or previous abdominal MRIs. An expert pancreatic MRI radiologist reviewed each image, looking for incidental pancreatic cysts. RESULTS: Of the 500 patients analyzed, 208 patients (41.6%) were found to have an incidental cyst. A significant relationship was observed between pancreatic cysts and patient age (P < .0001), diabetes mellitus (P = .001), and nonpancreatic cancer (P = .01), specifically nonmelanoma skin cancer (P = .03) or hepatocellular carcinoma (P = .02). The multivariable model showed a strong association between hardware and software versions and detection of cysts (P < .0001); the old hardware detected pancreatic cysts in 30.3% of patients, whereas the newest hardware detected cysts in 56.3% of patients. CONCLUSIONS: Based on an analysis of data collected from 2005 through 2014, newer versions of MRI hardware and software corresponded with higher numbers of pancreatic cysts detected. Older age, diabetes, and the presence of nonpancreatic cancer (specifically nonmelanoma skin cancer and hepatocarcinoma) were also associated with the presence of cysts.
BACKGROUND & AIMS: Increasingly, pancreatic cysts are discovered incidentally in patients undergoing cross-sectional imaging for nonpancreatic reasons. It is unclear whether this increase is caused by improved detection by progressively more sophisticated cross-sectional imaging techniques or by a true increase in prevalence. We aimed to determine the prevalence of incidental pancreatic cysts in patients undergoing magnetic resonance imaging (MRI) for nonpancreatic indications on successive, increasingly sophisticated MRI systems. Also, we compared prevalence based on the demographic characteristics of the patients. METHODS: We collected data from MRIs performed at the Mayo Clinic in Florida during the sample months of January and February, from 2005 to 2014. Each patient's clinical chart was reviewed in chronological order to include the first 50 MRIs of each year (500 total). Patients were excluded if they had pancreatic disease including cysts, pancreatic surgery, pancreatic symptoms, pancreatic indication for the imaging study, or previous abdominal MRIs. An expert pancreatic MRI radiologist reviewed each image, looking for incidental pancreatic cysts. RESULTS: Of the 500 patients analyzed, 208 patients (41.6%) were found to have an incidental cyst. A significant relationship was observed between pancreatic cysts and patient age (P < .0001), diabetes mellitus (P = .001), and nonpancreatic cancer (P = .01), specifically nonmelanoma skin cancer (P = .03) or hepatocellular carcinoma (P = .02). The multivariable model showed a strong association between hardware and software versions and detection of cysts (P < .0001); the old hardware detected pancreatic cysts in 30.3% of patients, whereas the newest hardware detected cysts in 56.3% of patients. CONCLUSIONS: Based on an analysis of data collected from 2005 through 2014, newer versions of MRI hardware and software corresponded with higher numbers of pancreatic cysts detected. Older age, diabetes, and the presence of nonpancreatic cancer (specifically nonmelanoma skin cancer and hepatocarcinoma) were also associated with the presence of cysts.
Authors: Sam L Ivry; Jeremy M Sharib; Dana A Dominguez; Nilotpal Roy; Stacy E Hatcher; Michele T Yip-Schneider; C Max Schmidt; Randall E Brand; Walter G Park; Matthias Hebrok; Grace E Kim; Anthony J O'Donoghue; Kimberly S Kirkwood; Charles S Craik Journal: Clin Cancer Res Date: 2017-04-19 Impact factor: 12.531
Authors: Shounak Majumder; William R Taylor; Tracy C Yab; Calise K Berger; Brian A Dukek; Xiaoming Cao; Patrick H Foote; Chung Wah Wu; Douglas W Mahoney; Harry R Aslanian; Carlos Fernández-Del Castillo; Leona A Doyle; James J Farrell; William E Fisher; Linda S Lee; Yvonne N Lee; Walter Park; Clifton Rodrigues; Bonnie Elyssa Gould Rothberg; Ronald R Salem; Diane M Simeone; Sumithra Urs; George Van Buren; Thomas C Smyrk; Hatim T Allawi; Graham P Lidgard; Massimo Raimondo; Suresh T Chari; Michael L Kendrick; John B Kisiel; Mark D Topazian; David A Ahlquist Journal: Am J Gastroenterol Date: 2019-09 Impact factor: 10.864
Authors: Pallavi Pandey; Ankur Pandey; Yan Luo; Mounes Aliyari Ghasabeh; Pegah Khoshpouri; Sanaz Ameli; Anne Marie O'Broin-Lennon; Marcia Canto; Ralph H Hruban; Michael S Goggins; Christopher Wolfgang; Ihab R Kamel Journal: Radiology Date: 2019-07-16 Impact factor: 11.105
Authors: Corbin Pontious; Sabrina Kaul; Marcus Hong; Phil A Hart; Somashekar G Krishna; Luis F Lara; Darwin L Conwell; Zobeida Cruz-Monserrate Journal: Pancreatology Date: 2019-09-20 Impact factor: 3.996
Authors: Giulia Zerboni; Gabriele Capurso; Marco Di Pietropaolo; Francesco Carbonetti; Elsa Iannicelli; Massimo Marignani; Gianfranco Delle Fave Journal: United European Gastroenterol J Date: 2017-02-09 Impact factor: 4.623
Authors: Kohei Fujikura; Waki Hosoda; Matthäus Felsenstein; Qianqian Song; Johannes G Reiter; Lily Zheng; Violeta Beleva Guthrie; Natalia Rincon; Marco Dal Molin; Jonathan Dudley; Joshua D Cohen; Pei Wang; Catherine G Fischer; Alicia M Braxton; Michaël Noë; Martine Jongepier; Carlos Fernández-Del Castillo; Mari Mino-Kenudson; C Max Schmidt; Michele T Yip-Schneider; Rita T Lawlor; Roberto Salvia; Nicholas J Roberts; Elizabeth D Thompson; Rachel Karchin; Anne Marie Lennon; Yuchen Jiao; Laura D Wood Journal: Gut Date: 2020-10-07 Impact factor: 23.059